Biljana Georgievska Rizoska

Biljana Georgievska Rizoska is a seasoned preclinical pharmacologist with extensive experience in drug discovery across various therapeutic areas, including viral infections, neuropathic pain, and oncology. Currently serving as Senior Director of In vivo Pharmacology & Toxicology at BioArctic since April 2018, Biljana has previously held roles such as Director of Pharmacology & Toxicology and Principal Scientist at Medivir AB, where responsibilities included coordinating safety studies and establishing biomarker strategies. Prior positions at AstraZeneca involved leadership in In vivo Neurology, managing teams and projects related to neurodegenerative diseases, while earlier experience included research roles at Lund University and Harvard Medical School. Biljana holds a PhD in Neuroscience from Lund University and a degree in Kemi/Biomedicin from Kalmar University.